Today, millions of Americans live with undetected hypertension, unaware that it can impact even the healthiest of individuals — a lesson that Naomi Saucer* would come to learn ...
Byram Healthcare, a leader in home-based care and part of the Owens & Minor (NYSE: OMI) family, recently launched ...
Aster DM Healthcare, a leading integrated healthcare provider in the GCC, has launched its flagship digital health platform, ...
Devonian Health Group Inc. (“Devonian” or the “Company”) (TSXV: GSD; OTCQB: DVHGF), a clinical stage corporation focused on ...
CRO” running radically faster, more reliable clinical trials, has announced their collaboration with the Clinical Data Interchange Standards Consortium (CDISC), to accelerate the generation of ...
A systematic review and meta-analysis estimating the differences in bleeding risks between therapeutic-dose non-vitamin K oral anticoagulants (NOACs) and single antiplatelet therapy (aspirin) found ...
A revolutionary new treatment called Targeted Thermal Therapy (Triple T) has shown promise as a safer, faster alternative to surgery ...
Heart disease is one of the leading causes of death on Guam and on Sunday, Dr. Peter Landless, a cardiologist, provided ...
Devonian Health Group Inc. (“Devonian” or the “Company”) (TSXV: GSD; OTCQB: DVHGF), a clinical stage corporation focused on developing unique solution ...
Nichols’ legacy serves as a reminder that although strides have been made toward inclusion, there is more that can be done to increase representation in the profession.
Two-year follow-up data from 34 subjects in the VenoValve pivotal trial show sustained clinical improvement and continued patient benefit, from 12 months to 24 months.78% of subjects maintained a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results